| RS1727731607 |
DOK7
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1727745724 |
DSPP
|
Health Risk |
Likely pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS1727756750 |
DSPP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness, autosomal dominant 39 |
| RS1727782355 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1727786451 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1727790591 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Renal cyst |
| RS1727810406 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1727814966 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1727827349 |
WDR19
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS1727874138 |
WDR19
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS1727922828 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1727923462 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1727938145 |
ADH5
|
Health Risk |
Pathogenic |
AMED syndrome, digenic |
| RS1728076151 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1728076436 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia, Methylmalonic aciduria |
| RS1728156204 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS1728162402 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1728203978 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1728415390 |
SEPSECS
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 2D, Pontocerebellar hypoplasia type 2D |
| RS1728474004 |
GABRB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 45 |
| RS1728584859 |
GABRB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 45 |
| RS1728590350 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1728633687 |
DOK7
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome 10 |
| RS1728635624 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1728646811 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 3, Fetal akinesia deformation sequence 1 |
| RS1728650830 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1728671600 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1728692644 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1728693166 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1728704616 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1728711651 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1728761079 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1728769445 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1728771454 |
OPA1
|
Health Risk |
Likely pathogenic |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS1728783958 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1728784661 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1728822488 |
CEP135
|
Health Risk |
Pathogenic |
— |
| RS1728848951 |
PITX2
|
Health Risk |
Pathogenic |
— |
| RS1728870745 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1728873590 |
PITX2
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 4, Axenfeld-Rieger syndrome type 1 |
| RS1728875550 |
PITX2
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis, Anterior segment dysgenesis |
| RS1728876351 |
WDR19
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS1728905695 |
OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS1728940158 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS17289589 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, See cases |
| RS1728991935 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1728998905 |
PITX2
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 1, Axenfeld-Rieger syndrome type 1 |
| RS1729000976 |
PITX2
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 4, Axenfeld-Rieger syndrome type 1 |
| RS1729001104 |
PITX2
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 4, Axenfeld-Rieger syndrome type 1 |
| RS1729003669 |
PITX2
|
Health Risk |
Likely pathogenic |
Anterior segment dysgenesis 4, Anterior segment dysgenesis 4 |
| RS1729007624 |
PITX2
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 4, Axenfeld-Rieger syndrome type 1 |
| RS1729018168 |
CEP135
|
Health Risk |
Pathogenic |
— |
| RS1729147441 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1729197529 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1729200967 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1729264976 |
WDR19
|
Health Risk |
Likely pathogenic |
Nephronophthisis 13, Asphyxiating thoracic dystrophy 5 |
| RS1729381211 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1729492561 |
FBXW7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cervical cancer, Colorectal cancer |
| RS1729554501 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1729654379 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1729663828 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1729681346 |
EVC
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1729718087 |
ANTXR2
|
Health Risk |
Pathogenic |
— |
| RS1729749153 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1729842757 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1729889650 |
INTU
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 20 with polydactyly, Orofaciodigital syndrome 17 |
| RS1729986593 |
MLC1
|
Health Risk |
Likely pathogenic |
— |
| RS1730078066 |
SEC24D
|
Health Risk |
Pathogenic |
— |
| RS1730087475 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1730088305 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1730093487 |
WDR19
|
Health Risk |
Likely pathogenic |
Nephronophthisis 13, Nephronophthisis 13 |
| RS1730099972 |
SEC24D
|
Health Risk |
Likely pathogenic |
— |
| RS1730132238 |
FGB
|
Health Risk |
Pathogenic |
— |
| RS1730293546 |
MANBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1730296951 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1730329392 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1730394064 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1730403199 |
PROM1
|
Health Risk |
Pathogenic |
Stargardt disease 4, Stargardt disease 4 |
| RS17304212 |
PJVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 59, Autosomal recessive nonsyndromic hearing loss 59 |
| RS1730456165 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 41, Autosomal dominant nonsyndromic hearing loss 6 |
| RS1730514795 |
WDR19
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS1730515128 |
WDR19
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS1730535406 |
WDR19
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS1730552437 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1730600472 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1730623318 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1730640591 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1730695660 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS1730760070 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1730766213 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1730784665 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1730786293 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1730806684 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 2, Van Maldergem syndrome 2 |
| RS1730824213 |
CEP135
|
Health Risk |
Pathogenic |
Microcephaly 8, primary |
| RS1730863609 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1730884546 |
WFS1
|
Health Risk |
Pathogenic |
Diabetes mellitus, Wolfram syndrome 1 |
| RS1730892028 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS1730907876 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS1730924133 |
WFS1
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Wolfram syndrome 1, WFS1-related disorder |
| RS1730930342 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Cataract 41 |